From the Journals

Resistant hypertension hits SLE patients hard


 

FROM ARTHRITIS CARE & RESEARCH

Patients with systemic lupus erythematosus (SLE) were 72% more likely to have resistant hypertension than were control patients at a tertiary care center.

wildpixel/Thinkstock

A patient with resistant hypertension either has blood pressure remaining above 140/90 mm Hg while taking three antihypertensive medications or requires the use of four or more antihypertensives to attain blood pressure control. Resistant hypertension, which was more likely to occur among blacks and patients with lower renal function, hypercholesterolemia, and increased inflammatory markers, increased the risk of death nearly threefold (hazard ratio, 2.91; P = .0005) when compared with those who didn’t have this condition.


The results of this analysis were published March 15 in Arthritis Care & Research (doi: 10.1002/acr.23880). We covered this study at the 2018 annual meeting of the American College of Rheumatology in Chicago before it was published in the journal. Read our previous story at the link above.

Recommended Reading

New findings raise questions about the role of ANAs in SLE
MDedge Rheumatology
Ehlers-Danlos syndrome: Increased IUGR risk reported
MDedge Rheumatology
List of medications linked to drug-induced lupus expands
MDedge Rheumatology
Dr. Lisa Christopher-Stine: Polymyositis? It’s more likely something else
MDedge Rheumatology
Vagus nerve stimulation for rheumatology? Maybe
MDedge Rheumatology
Amyloid PET may help facilitate diagnosis of inclusion body myositis
MDedge Rheumatology
Myositis mimics: Clues for making the right diagnosis
MDedge Rheumatology
Rheumatologist involvement often reclassifies interstitial lung disease
MDedge Rheumatology
Belimumab data out to 13 years show continued safety, efficacy
MDedge Rheumatology
BTK inhibitor calms pemphigus vulgaris with low-dose steroids
MDedge Rheumatology